Inventor · disambiguated record
Paul D. Van Poelje
Also filed as: VAN POELJE PAUL D
7 granted patents·3 pending applications·73 citations·filing 1999–2019
84Inventor score
Top patents by PatentIndex Score
10 records- 0187US8710236B2Antagonists of the glucagon receptorGOMEZ-GALENO JORGE E·Filed 2011·Granted Apr 29, 2014·10 cites·5 claims
- 0286US9701626B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2015·Granted Jul 11, 2017·5 cites·10 claims
- 0386US9169201B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·8 cites·13 claims
- 0482US6756360B1Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetesMETABASIS THERAPEUTICS INC·Filed 1999·Granted Jun 29, 2004·48 cites·74 claims
- 0580US10239829B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·2 cites·20 claims
- 0669US2008004226A1Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of DiabetesMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 0768US10807946B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2019·Granted Oct 20, 2020·0 cites·10 claims
- 0865US2009197836A1Combination of FBPase Inhibitors and Antidiabetic Agents Useful for the Treatment of DiabetesVAN POELJE PAUL D·Filed 2007·Application pending·0 cites
- 0962US2004167178A1Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetesFiled 2004·Application pending·0 cites
- 1053US7563774B2Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetesMETABASIS THERAPEUTICS INC·Filed 2001·Granted Jul 21, 2009·0 cites·33 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →